Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. This rating represents a strong Buy recommendation, on the scale from 1 … 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 (29.74% Upside) Based on 6 analysts offering 12 month price targets for Bristol Myers in the last 3 months. 11 Wall Street analysts that have issued a 1 year BMY price target, the average BMY price target is $73.09, with the highest BMY stock price forecast at $80.00 and the lowest BMY stock price forecast at $66.00. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Your current $100 investment may be up to $111.15 in 2026. A number of other hedge funds also recently made changes to […] Historical daily share price chart and data for Bristol Myers Squibb since 1972 adjusted for splits. Aaron Wealth Advisors purchased a new position in Bristol-Myers Squibb (NYSE:BMY) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. Receive a free world-class investing education from MarketBeat. The average price target is $77.83 with a … There are currently 4 hold ratings, 10 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy." View today's stock price, news and analysis for Bristol Myers Squibb Co. (BMY). Identify stocks that meet your criteria using seven unique stock screeners. According to . Their average twelve-month price target is $74.27, predicting that the stock has a possible upside of 23.78%. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. Given the current horizontal trend, you can expect Bristol-Myers Squibb Company stock with a 90% probability to be traded between $59.99 and $67.05 at the end of this 3-month period. The dark blue line represents the company's actual price. $77.83. The high price target for BMY is $88.00 and the low price target for BMY is $65.00. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Take-Two price target raised to $204 from $199 at Credit Suisse 07:25 Today Barclays Take-Two price target raised to $220 from $210 at Barclays. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. Analyst Price Target on BMY. BMY-R price target in 14 days: 3.509 USD* upside and 2.861 USD* downside. View which stocks are hot on social media with MarketBeat's trending stocks report. Zacks Investment Research - 1 week ago What's in the Cards for Bristol-Myers' (BMY) Q4 Earnings? Bristol Myers Squibb Co. analyst ratings, historical stock prices, earnings estimates & actuals. Stocks turning up in the middle of a horizontal trend … Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BMY shares is $74.94 per share. Learn about financial terms, types of investments, trading strategies and more. Bristol-Myers Squibb had a return on equity of 48.72% and a net margin of 22.23%. Bristol Myers Squibb Co. analyst estimates, including BMY earnings per share estimates and analyst recommendations. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. The biopharmaceutical company reported $1.10 EPS for the quarter, beating the consensus estimate of $1.09 by $0.01. © American Consumer News, LLC dba MarketBeat® 2010-2021. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Learn more. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Export data to Excel for your own analysis. Get the latest Zacks research report on BMY — FREE. Bristol-Myers Squibb Co (NYSE:BMY) posted its earnings results on Thursday, April, 25th. And so with BMY crossing above that average target price of $64.00/share, investors in BMY have been given a good signal to spend fresh time … The average price target represents a 54.55% increase from the … Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing. Do Not Sell My Information. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . - Try Now Risk-Free - Money-back guarantee! 1 Wall Street analysts have issued ratings and price targets for Bloomsbury Publishing plc (BMY.L) in the last 12 months. Start Your Risk-Free Trial Subscription Here, Sociedad Quimica Stock is a Real Deal EV Lithium Play, Global shares extend gains on global optimism, vaccine hopes, Luxury car brand Jaguar to go all-electric by 2025, Tokyo surges to 30-year high as world shares rally, World stocks rally, bringing Japanese market to 30-year high, Biden faces questions about commitment to minimum wage hike, Revisiting Limelight Networks Stock as a Streaming Winner, Sketchers U.S.A. Stock is a Pullback Opportunity Here, 3 Stocks Under $20 Set for Big 2021 Gains, 3 Dating App Stocks for Investors to Love, 3 Consumer Discretionary Stocks Ready to Run, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, Receive Analysts' Upgrades and Downgrades Daily. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Fundamental company data provided by Zacks Investment Research. As of 2021 February 12, Friday current price of BMY stock is 59.975$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Bristol Myers Squibb Co. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. With a 5-year investment, the revenue is expected to be around +11.15%. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. The average analyst price target of BMY is greater than 88.24% of Pharmaceutical Products stocks. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Buy in pull back with stop level below 59.90 for target above 67. BMY: Get the latest Bristol-Myers Squibb stock price and detailed information including BMY news, historical charts and realtime prices. Learn more. The lighter blue line represents the stock's consensus price target. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. See what's happening in the market right now with MarketBeat's real-time news feed. Here is what top equities market gurus are saying about Bristol-Myers Squibb Company [BMY]: Based on careful and fact … All rights reserved. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BMY stock is a recommendation set at 1.90. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Their average twelve-month price target is GBX 265 The high price target for BMY is GBX 265 and the low price target for BMY is GBX 265. Beta is a measure of volatility relative to the stock market at large; for BMY, its beta is lower than 93.6% of stocks in the large-sized revenue class. BMY - It is in 3rd of C of Y wave up. The fund purchased 18,666 shares of the biopharmaceutical company’s stock, valued at approximately $1,157,000. All rights reserved. You can opt out at any time. View which stocks are hot on social media with MarketBeat's trending stocks report. Learn more. Average Price Target. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. The chart below shows how a company's share price and consensus price target have changed over time. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. View our full suite of financial calendars and market data tables, all for free. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. EKSO Ekso Bionics $13.04 / +2.59 (+24.78%) 06/26/20 H.C. Wainwright Ekso Bionics price target raised to $12 from $8 at H.C. Wainwright. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. The company's revenue for the quarter was up 14.0% on a year-over-year basis. Export data to Excel for your own analysis. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. On November 30, 2020 "Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell" gave "" rating for BMY. To see all exchange delays and terms of use please see disclaimer. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the roof. Prices shown are actual historical values and are not adjusted for either splits or dividends. Bristol Myers Squibb Co's variance in analysts' estimates is lower than 77.79% of stocks in the large market cap category. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. If compared to the average trading volume of 10.35M shares, BMY reached a trading volume of 10236162 in the most recent trading day, which is why market watchdogs consider the stock to be active. View our full suite of financial calendars and market data tables, all for free. Bloomsbury Publishing plc (BMY.L) (LON:BMY) Consensus Price Target History Average Share Price and Price Target by Month The high price target for BMY is $88.00 and the low price target for BMY is $65.00. Looking for new stock ideas? The Average True Range (ATR) for Bristol-Myers Squibb Company is set at 1.28, with the Price to Sales ratio for BMY stock in the period of the last 12 months amounting to 3.72. Start Your Risk-Free Trial Subscription Here, Sociedad Quimica Stock is a Real Deal EV Lithium Play, Global shares extend gains on global optimism, vaccine hopes, Luxury car brand Jaguar to go all-electric by 2025, Tokyo surges to 30-year high as world shares rally, World stocks rally, bringing Japanese market to 30-year high, Biden faces questions about commitment to minimum wage hike, Revisiting Limelight Networks Stock as a Streaming Winner, Sketchers U.S.A. Stock is a Pullback Opportunity Here, 3 Stocks Under $20 Set for Big 2021 Gains, 3 Dating App Stocks for Investors to Love, 3 Consumer Discretionary Stocks Ready to Run, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Receive Analysts' Upgrades and Downgrades Daily.